Niraparib efficacy in patients with unresectable mesothelioma: a randomised phase II trial of niraparib versus active symptom control in patients with previously treated mesothelioma: NERO (TRIALS IN PROGRESS). (April 2023) - Fennell, Dean; Griffiths, Daniel; Eminton, Zina; Morgan-Fox, Abigail; Hill, Kayleigh; Nearchou, Theodora; Johnson, Lucy; Harding, Stephanie; Poile, Charlotte; Bzura, Aleksandra; Spicer, Jake; Nye, Mavis; et al.